Patent · US Expired

Gamma lactams as prostaglandin agonists and use thereof

US7419999B2 · kind B2 · utility

13Cited by
9References
42Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 9, 2003
Grant dateSep 2, 2008
Priority date
Expiry dateJul 3, 2023

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D409/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

1,2-substituted 5-pyrrolidinone compounds are provided, and methods of treatment and pharmaceutical composition that utilize or comprise one or more such compounds. Compounds of the invention are useful for a variety of therapies, including treating or preventing preterm labor, dysmenorrhea, asthma, hypertension, infertility or fertility disorder, undesired blood clotting, preeclampsia or eclampsia, an eosinophil disorder, sexual dysfunction, osteporosis and other destructive bone disease or disorder, renal dysfunction, an immune deficiency disorder, dry eye, ichthyosis, elevated intraocular pressure, sleep disorder, or gastric ulcer, inflammatory disorders and other diseases and disorders associated with the prostaglandin family of compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.